Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.65 EUR
−10.86 M EUR
0.00 EUR
11.44 M
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of K6S is 1.24 EUR — it has increased by 5.08% in the past 24 hours. Watch MIRA PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MIRA PHARMACEUTICALS INC stocks are traded under the ticker K6S.
K6S stock has fallen by −10.14% compared to the previous week, the month change is a 30.53% rise, over the last year MIRA PHARMACEUTICALS INC has showed a −40.95% decrease.
We've gathered analysts' opinions on MIRA PHARMACEUTICALS INC future price: according to them, K6S price has a max estimate of 16.56 EUR and a min estimate of 7.00 EUR. Watch K6S chart and read a more detailed MIRA PHARMACEUTICALS INC stock forecast: see what analysts think of MIRA PHARMACEUTICALS INC and suggest that you do with its stocks.
K6S stock is 8.47% volatile and has beta coefficient of −4.07. Track MIRA PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is MIRA PHARMACEUTICALS INC there?
Yes, you can track MIRA PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
MIRA PHARMACEUTICALS INC is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
K6S net income for the last quarter is −1.84 M EUR, while the quarter before that showed −1.58 M EUR of net income which accounts for −16.25% change. Track more MIRA PHARMACEUTICALS INC financial stats to get the full picture.
No, K6S doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 3.00 employees. See our rating of the largest employees — is MIRA PHARMACEUTICALS INC on this list?
Like other stocks, K6S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MIRA PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.